These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 176295)

  • 1. Tamoxifen as an anti-tumour agent: effect on oestrogen binding.
    Jordan VC; Dowse LJ
    J Endocrinol; 1976 Feb; 68(02):297-303. PubMed ID: 176295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour response.
    Jordan VC; Jaspan T
    J Endocrinol; 1976 Mar; 68(3):453-60. PubMed ID: 1255105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen as an anti-tumour agent: role of oestradiol and prolactin.
    Jordan VC; Koerner S
    J Endocrinol; 1976 Feb; 68(02):305-11. PubMed ID: 815505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oestradiol-17beta and tamoxifen on nuclear oestradiol-17beta receptors in DMBA-induced rat mammary tumours.
    Nicholson RI; Davies P; Griffiths K
    Eur J Cancer (1965); 1977 Mar; 13(3):201-8. PubMed ID: 405219
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of oestradiol - 17beta and tamoxifen on total and accessible cytoplasmic oestradiol - 17beta receptors in DMBA-induced rat mammary tumours.
    Nicholson RI; Golder MP; Davies P; Griffiths K
    Eur J Cancer (1965); 1976 Sep; 12(9):711-7. PubMed ID: 823027
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.
    Jordan VC; Allen KE
    Eur J Cancer (1965); 1980 Feb; 16(2):239-51. PubMed ID: 6768559
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of pregnant mares serum gonadotrophin on the response of DMBA induced rat mammary tumours to tamoxifen or oestrogen.
    Clark ER; Robinson SP; Whitaker EM; Zoltowski JA
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1843-50. PubMed ID: 2517258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early increases in ribonucleic acid polymerase activities of dimethylbenzanthracene-induced mammary tumour nuclei in response to oestradiol-17beta and tamoxifen.
    Nicholson RI; Davies P; Griffiths K
    J Endocrinol; 1977 Apr; 73(1):135-42. PubMed ID: 404379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas.
    Maucher A; von Angerer E
    J Cancer Res Clin Oncol; 1994; 120(8):502-4. PubMed ID: 8207051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens.
    Jordan VC; Naylor KE
    Br J Pharmacol; 1979 Feb; 65(2):167-73. PubMed ID: 760895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Specificity of steroid binding by the oestrogen receptor of rat mammary tumours induced by 7,12-dimethylbenz(a)anthracene.
    Powell-Jones W; Davies P; Wilson DW; Griffiths K
    J Endocrinol; 1976 Mar; 68(3):30P. PubMed ID: 176305
    [No Abstract]   [Full Text] [Related]  

  • 13. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.
    Wakeling AE; Valcaccia B
    J Endocrinol; 1983 Dec; 99(3):455-64. PubMed ID: 6644236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered uterine sensitivity to oxytocin and prostaglandin F2 alpha in dimethylbenz(a)anthracene (DMBA)-induced rat mammary carcinoma: the effects of tamoxifen and/or recombinant human interferon alpha 2b therapy.
    Badary OA; Agha AM; el-Sayed ES; Hamada FM
    Pharmacol Res; 1996; 34(3-4):99-103. PubMed ID: 9051698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ovariectomy, tamoxifen and the combination adriamycin and 5-FU on 7,12-dimethylbenz(a)anthracene induced mammary cancer of the rat.
    Fiebig HH; Schmähl D
    Oncology; 1977; 34(2):58-61. PubMed ID: 408773
    [No Abstract]   [Full Text] [Related]  

  • 17. The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours.
    Daniel CP; Gaskell SJ; Nicholson RI
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):137-43. PubMed ID: 6420159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata.
    Jordan VC
    Eur J Cancer (1965); 1976 Jun; 12(6):419-24. PubMed ID: 821733
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.
    Jordan VC
    Cancer Treat Rep; 1976 Oct; 60(10):1409-19. PubMed ID: 828517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a mathematical model for two component receptor binding to two high affinity oestrogen binding sites in nuclei from DMBA rat mammary tumours.
    Clark ER; Mackay D; Robinson SP
    J Steroid Biochem; 1988 Apr; 29(4):375-80. PubMed ID: 3131591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.